Today we are really thrilled and proud to officially announce that we have finally closed the deal with Dr. Charles R. Cantor who had become not only our respectful adviser but also a shareholder!
After more than a year of negotiations followed by full disclosure and discussion of our technology, Dr. Cantor has kindly agreed to join our team. We strongly believe that such really important new member of our project will help us with a lot of matters in the foreseeable future.
Dr. Cantor is worldwide known for the development of pulse field gel electrophoresis for very large DNA molecules. He is the author of more than 400 articles, 54 US patents, and various books. Dr. Cantor is actively consulting more than 16 biotech firms all around the globe.